HomeNewsUsing PET to elucidate novel glucose metabolism in cancer
Using PET to elucidate novel glucose metabolism in cancer
For decades, FDG (18F-fluorodeoxyglucose) imaging has been a standard clinical method for diagnosing and monitoring cancer. But new research harnessing the technique has challenged what we know about how it – and cancer cells – work. Read more.